semaglutide soul trial: Oral demonstrates a 14% reduction in risk of major adverse CV events ACC 25 Late-Breaking Discussion: SOUL:

Both ship free with same-day processing

Facile synthesis of a biocompatible silver nanoparticle derived tripeptide supramolecular hydrogel for antibacterial wound dressings

Your GP will also monitor weight, blood pressure, and overall metabolic health

Sources of Information Used by the Committee To make its recommendation, the committee considered the following information: a review of 1 RCT in patients with established CVD and overweight or obesity and without diabetes, and 1 RCT in patients with T2DM at high risk of CV events patients perspectives gathered by 6 patient groups: Gastrointestinal Society (GI Society), Obesity Canada, Obesity Matters, Fatty Liver Alliance, HeartLife Foundation, and Diabetes Canada input from public drug plans that participate in the reimbursement review process two clinical specialists with expertise diagnosing and treating patients with overweight and obesity and CVD input from 4 clinician groups: TotalCardiology Rehabilitation, Cardiac Rehabilitation and Secondary Prevention Program, Obesity Canada, and the Canadian Association for Bariatric Physicians and Surgeons a review of the pharmacoeconomic model and report submitted by the sponsor

View image online ( Closeup of nasal tanning spray being used in nose

17 ThethiTKPratleyRMeierJJ